gimme.care
A permanent record of what we could see on 2026-08-31. Share it, cite it, or download it.
Telehealth platform offering compounded GLP-1 and peptide therapies sourced from US pharmacies.
Gimme Care (Start Gimme LLC) operates a US-based telehealth platform matching patients with licensed healthcare providers and US compounding pharmacies for GLP-1 and peptide therapies. Pricing covers medical consultations, prescriptions, supplies, and cold-chain shipping. Independent third-party laboratory test reports are not published on the site.
Confidence: high · 6 pages read · 0 documents opened · 2026-08-31 13:06 UTC
We could read most of what matters, lab evidence included.
Mixed. Below the median of the 31 research suppliers we have scored (6.7).
- Strong8.0 – 10
- Good6.5 – 7.9
- Mixed5.0 – 6.4
- Weak0 – 4.9
- 1The site acts as a telehealth platform and does not publish third-party laboratory analysis or batch COAs for its products.
- 2No specific compounding pharmacy names are disclosed prior to consultation.
Third-party test reports: are they recent, lot-linked, and do they use methods that can actually prove identity and amount?
- Published test reportsFlagged
We found no certificate or test-report links anywhere we could read on the site. For a research-use seller this is the single most important thing to publish.
- Reports tied to a lotNot visible
No documents to trace back to a batch.
- What the reports sayFlagged
No third-party laboratory reports or independent testing certificates are provided on the site.
- Analytical methodNot visible
No analytical method (HPLC, LC-MS, mass spec) is named anywhere we could read. Purity claimed without a method is a number without a source.
- Named third-party labNot visible
No outside laboratory is named. In-house numbers are not independent evidence.
- Document recencyNot visible
The documents carry no date we could read from the server.
Third-party ratings and public threads, read directly at the moment of this check. They are easy to buy and easy to brigade, so they are weighted low and can never overturn a lab-evidence flag. Every source below is also logged in the evidence trail.
Trustpilot did not answer, so we treat their reputation there as not visible.
Read 2026-08-31 13:06 UTC
No Google rating we could read from here. Google blocks automated reads, so open the link and judge it yourself.
Read 2026-08-31 13:06 UTC
No public community discussion we could read. Silence is not a verdict either way.
Read 2026-08-31 13:06 UTC
Every claim in this report traces to one of the items above. Expand a row to see the material it is based on.
The score is a weighted mean over the pillars we could actually read — 88% of the model on this run. Anything we could not see is left out of the maths rather than counted against the seller.
Model weight 34% · pillar score 0.0/10 · 0 ok, 2 flagged, 4 unseen
Model weight 24% · pillar score 6.7/10 · 2 ok, 1 flagged, 4 unseen
Model weight 18% · pillar score 10.0/10 · 1 ok, 0 flagged, 2 unseen
Model weight 12% · pillar score 10.0/10 · 2 ok, 0 flagged, 1 unseen
Model weight 12% · nothing readable · 0 ok, 0 flagged, 3 unseen
Reputation is deliberately the lightest pillar. Even a perfect rating cannot lift a report over a lab-evidence flag.
Paste the citation straight into a paper or a reference manager. Both files carry the run identifier and the timestamp of this report.
MyDosage. MyDosage supply check: gimme.care (5.2/10). 2026-08-31. https://mydosage.com/c/d81d9681-e1bd-42ff-a0ce-b7eb4856fdba
The pack is one PDF: the verdict page plus an appendix of every cited page, document and social-proof source with the text we read. The data exports carry the same thing in machine form — inputs, every source with its timestamp and confidence weight, and the full scoring breakdown.
Whatever this report said, there are three ways to get what you need.
- 1Doctor + approved medicineA prescription and a pharmacy-dispensed product with a regulator's label.
- 2Clinic + licensed compounding pharmacyA prescriber and a pharmacy we checked against its licence register.
- 3Research-use-only supplierNo medical oversight. Only worth it when nothing approved exists yet.
Prices, oversight and typical wait are compared side by side for United States.